Healthequity Inc (NASDAQ:HQY) EVP Delano Ladd sold 26,405 shares of Healthequity stock in a transaction dated Tuesday, December 12th. The shares were sold at an average price of $43.32, for a total value of $1,143,864.60. Following the completion of the transaction, the executive vice president now directly owns 16,692 shares of the company’s stock, valued at $723,097.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of Healthequity Inc (HQY) traded up $0.78 during trading hours on Thursday, reaching $44.54. The company’s stock had a trading volume of 520,800 shares, compared to its average volume of 533,107. The company has a market cap of $2,690.00, a PE ratio of 62.51, a P/E/G ratio of 1.81 and a beta of 1.74. Healthequity Inc has a 12-month low of $37.62 and a 12-month high of $55.31.

Healthequity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.13 by $0.04. The firm had revenue of $56.80 million during the quarter, compared to analysts’ expectations of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The company’s quarterly revenue was up 31.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.10 EPS. analysts forecast that Healthequity Inc will post 0.71 earnings per share for the current fiscal year.

A number of research analysts recently issued reports on the company. BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a report on Tuesday, November 7th. Zacks Investment Research raised Healthequity from a “hold” rating to a “buy” rating and set a $58.00 price target for the company in a report on Wednesday, October 11th. Robert W. Baird reaffirmed a “hold” rating on shares of Healthequity in a report on Thursday, September 21st. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $56.00 price target on shares of Healthequity in a report on Tuesday, December 5th. Finally, Chardan Capital lifted their price target on Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a report on Wednesday, December 6th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eight have assigned a buy rating to the company. Healthequity currently has an average rating of “Buy” and a consensus price target of $58.33.

Large investors have recently made changes to their positions in the business. Zions Bancorporation bought a new stake in Healthequity during the 3rd quarter worth about $119,000. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Healthequity by 105.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,544 shares of the company’s stock worth $127,000 after buying an additional 1,308 shares during the period. Riverhead Capital Management LLC grew its position in shares of Healthequity by 75.3% during the 2nd quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock worth $131,000 after buying an additional 1,129 shares during the period. Oppenheimer Asset Management Inc. grew its position in shares of Healthequity by 7.7% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock worth $134,000 after buying an additional 191 shares during the period. Finally, Fortaleza Asset Management Inc. acquired a new position in shares of Healthequity during the 2nd quarter worth about $138,000. 98.60% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: “Healthequity Inc (HQY) EVP Delano Ladd Sells 26,405 Shares” was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with's FREE daily email newsletter.